This is what I am talking about when I criticize an investor's decision to make an immediate posting that suggests negative things about the company just when it is clearly making positive headway. Instead of finding out the actual facts, if someone assumes the worst case scenario and puts it out in hyperspace for all to see, including people who might be otherwise interested in buying shares, then it is not only wrong but harmful to the company and to existing investors. I am in no way suggesting we should hype or puff based on inaccurate data, but when it is a very positive development as indicated by Eudius and Number1 it is most useful if we recognize that, comment on it, or at least keep our mouths shut if we do not have valid information. Eudius and Number1 obtained and provided valid and positive information after going to the source to obtain it. I appreciate that very much as should we all. One thing it is not good to do is to go off half-cocked to criticize the company when the facts are not known.
I also appreciate the fact that the CEO was as open as possible without providing insider information. I have said before that the time to publish significant financial information will be when that report is indicative of a continuous and significant condition that demonstrates ongoing success. We have seen previously that financial reports have otherwise ended up being the subject of attack to the point of undermining the perception of the company. This latest development contributes to a positive sense of developing conditions and I hope as you do that it continues upward and expands venues and partnerships. I also am waiting eagerly for the commercialized stage of the N-Assay.